Method of treatment of hypoxia/ischaemia
AssigneesUniversitair Medisch Centrum Utrecht, Universiteit Utrecht Holding B. V.
InventorsWouter Bernard, Petrus Hendrikus van der Meide, Klaas Nicolay
Life of this patent
Estimating the term…
Abstract
The present invention provides means and methods for at least a partial prevention of cellular damage in disease resulting from H/I-related blood flow resistance, preferably due to occlusion of blood vessels. Administration of β-interferon before, around or after the time of lifting of the ischemia results in improved survival of cells downstream of the occluded blood vessel, presumable because micro-vasculature downstream of the lifted obstruction if prevented from clogging. Prevention of blood flow impairment presumably leads to increased survival of cells in tissue affected by the ischemia.
Claims17
A method for treating hypoxia/ischemia (H/I) related blood flow resistance in an individual, said method comprising:
- administering to the individual a suitable dose of interferon-β or a functional part, derivative and/or analogue thereof.
A method for treating an H/I related blood flow resistance in an individual, wherein the individual has at least one blood vessel obstruction causing ischaemia in tissue that is situated downstream from said obstruction, said method comprising:
- administering to the individual a therapeutic dose of interferon-β or a functional part, derivative and/or analogue thereof.
A method for at least in part improving blood flow in post-ischemic tissue, said method comprising:
- administering to an individual, having said tissue, β-interferon or a functional part, derivative and/or analogue thereof.
A method for at least in part preventing cell death in post-ischemic tissue, said method comprising:
- administering to an individual having said tissue, β-interferon or a functional part, derivative and/or analogue thereof.
Dependencies are inferred from the claim text.